The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PD-L1 expression in non-clear cell renal cell carcinoma.
André P Fay
No relevant relationships to disclose
Marcella Callea
No relevant relationships to disclose
Kathryn P. Gray
No relevant relationships to disclose
Thai Huu Ho
No relevant relationships to disclose
Jiaxi Song
No relevant relationships to disclose
Ingrid Carvo
No relevant relationships to disclose
Megan E. Lampron
No relevant relationships to disclose
Melissa L. Stanton
No relevant relationships to disclose
David F. McDermott
Consultant or Advisory Role - Bristol-Myers Squibb; Genentech; Merck
Michael B. Atkins
Consultant or Advisory Role - Bristol-Myers Squibb; Merck; Prometheus
Gordon J Freeman
Consultant or Advisory Role - Costim Pharmaceuticals
Research Funding - Amplimmune; Boehringer-Mannheim; Bristol-Myers Squibb; Costim Pharmaceuticals ; EMD Serono; Genentech/Roche; Merck
Michelle S. Hirsch
No relevant relationships to disclose
Sabina Signoretti
No relevant relationships to disclose
Toni K. Choueiri
Consultant or Advisory Role - AVEO; Exelixis; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Pfizer